Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flexible sigmoidoscopy comfort study with video education and Entonox
ACTRN12621000918820Phase 4Completed
- Sponsor
- Philip Bagshaw
- Start
- Sep 2021
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of nitrous oxide + oxygen in hematochezia (3 arms), sponsored by Philip Bagshaw. Primary endpoints: Video questionnaire and self-assessed anxiety score, Nurse-generated participant comfort score and 1 more. Started Sep 2021; status: completed.
02
Drugs
nitrous oxide + oxygen
03
Conditions
hematochezia
Beyond the preview
Go deeper on ACTRN12621000918820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621000918820.